Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials

Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials

Abstract Introduction The aim of our work is to assess the prevalence of probable major depressive disorder and/or probable generalized anxiety disorder (pMDD/pGAD) in patients with moderate to severe rheumatoid arthritis (RA), and to evaluate the efficacy of tofacitinib on RA symptoms stratified by...

Full description

Bibliographic Details
Main Authors: Gustavo Citera, Rakesh Jain, Fedra Irazoque, Hugo Madariaga, David Gruben, Lisy Wang, Lori Stockert, Karina Santana, Abbas Ebrahim, Dario Ponce de Leon
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Rheumatology and Therapy
Subjects:
Anxiety
JAK inhibitor
Rheumatoid arthritis
Tofacitinib
Online Access:https://doi.org/10.1007/s40744-023-00612-7

Internet

https://doi.org/10.1007/s40744-023-00612-7

Similar Items